Maxcyte Inc

MaxCyte Inc is a US-based life sciences company providing an innovative cell-engineering platform. Its primary aim is to advance cell-based therapies and drug discovery by enabling complex cell modifications. The company supports global biopharmaceutical partners. Operating within the biotechnology and healthcare sector, MaxCyte Inc specialises in flow electroporation technology. This proprietary approach facilitates non-viral delivery of molecules, supporting cell-based therapeutic development and drug discovery aimed at potential medical breakthroughs. Keep up to date on the latest share price changes by adding MXCT.L stock to your eToro watchlist. This content was generated by artificial intelligence. We cannot guarantee the accuracy, completeness, or timeliness of the information provided.